Periodic Reporting for period 1 - WASABI (Towards the Wider uptake of Arterial Stiffness As a BIomarker for cardiovascular diseases)
Reporting period: 2015-12-01 to 2016-05-31
ALAM Medical, specialized in arterial stiffness and central pressure, has initiated the WASABI project to scale up the clinical use of PWV as a biomarker, notably by investigating alternative sensors in or-der to offer an easier to use and more affordable device measuring gold standard aortic stiffness and local carotid stiffness. By providing a medical device with such characteristics, as well as by under-taking appropriate market awareness actions, we intend to transform our existing niche market, main-ly composed of clinical researchers, into a large-scale market composed of clinical practitioners, car-diologists or physicians: arterial stiffness measurements have the potential to move from research to standard medical practice, on the model of blood pressure measurements.
During project Phase 1, ALAM Medical has investigated several sensor technologies to measure ca-rotid-femoral PWV, the gold standard methodology for arterial stiffness. The evaluation results of the sensors evaluation led ALAM MEDICAL to re-orientate the WASABI project toward another solution to assess arterial stiffness. ALAM Medical performed in-depth market survey, started a R&D collabora-tion project with another company and elaborated a business plan to work with them.
We have started to add central pressure measurement to their device and are about to add brachial-ankle PWV. We already show the new product at a international medical congress. For future commercialisation, we will take advantage of their existing distribution network which includes most European countries, USA and Canada as well as most active emerging countries active in health management. We will also take advantage of their existing customers and offer a specific package to update their equipment to also have central pressure and arterial stiffness functionalities.